NCT00615927 2013-03-15Phase II Imatinib + Hydroxyurea in Treatment of Patients With Recurrent/Progressive Grade II Low-Grade Glioma (LGG)Duke UniversityPhase 2 Completed64 enrolled 9 charts
NCT00354913 2013-01-18Imatinib Mesylate and Hydroxyurea in Treating Patients With Recurrent or Progressive MeningiomaDuke UniversityPhase 2 Completed21 enrolled 8 charts